Table 1.
Neurorehabilitation in the COVID‐19 world: current challenges and actions to minimize COVID‐19 risks in different settings of neurorehabilitation, and possible drawbacks to be overcome before continuing on previous healthcare activities.
| Challenge | Actions | Drawbacks |
|---|---|---|
| Reduce inpatient and outpatient visits | Telerehabilitation and teleconsultations |
To be made widely available Not feasible for complex diseases or severe symptoms Periodic in‐person assessments needed |
| Outpatient and day service | Screening for body temperature and active respiratory symptoms | Asymptomatic patients are missed |
| SARS‐CoV‐2 oro‐pharyngeal swab and/or serological testing, according to local regulations | To be made widely available | |
| Physical distancing |
Reduced number of simultaneous treatments Longer opening hours Caregivers and visitors not allowed to access |
|
| Appropriate personal protective equipment for operators and patients | To be made available at population level | |
| Inpatient | Screening for body temperature and active respiratory symptoms | Asymptomatic patients are missed |
| SARS‐CoV‐2 oro‐pharyngeal swab and/or serological testing on admission, according to local regulations | To be made widely available | |
| Separate pathways | To be considered within hospital reorganization plans | |
| Staff and patients’ protection | Personal protective equipment | To be made widely available |
| Robot‐assisted neurorehabilitation | To be made widely available | |
| Contact tracing apps | Depending on national regulations | |
| Patients with active COVID‐19 infection | NeuroCOVID‐19 wards and/or COVID‐19 hospitals | To be made widely available |